论文部分内容阅读
心力衰竭（心衰）是各种心脏疾病的严重和终末阶段，已经成为影响我国居民健康的重要公共卫生问题。针对目前我国心衰规范化诊治方面存在的问题，积极开展心衰医疗质量评价和改进，提高心衰诊治的规范性，具有重要的意义。自从2018年3月成立国家心血管病中心心力衰竭专病医联体（HFMU-NCCD），加入医院已超过1 000家。国家心血管病医疗质量控制中心专家委员会心力衰竭专家工作组（NCCQI-HF）纳入2017~2020年期间在医联体单位住院的心衰患者，开展全国心衰医疗质量评价，包括心衰的诊断与评估、指南指导的药物治疗及器械治疗、临床结局等，并依据该研究结果和我们的思考，撰写成本报告。此外，还与美国心脏学会（AHA）的“跟着指南走——心力衰竭”（GWTG-HF）项目结果作比较，发现当前我国在心衰诊疗规范化方面存在的问题，确定未来质量改进的目标和方法，以便从整体上提高我国心衰的诊治水平。“,”Heart failure (HF) is the advanced manifestation of various heart diseases and has become an important public health problem affecting Chinese adult residents. In view of the problems existing in the standardization of diagnosis and treatment of HF in China, it is of great significance to actively carry out the medical quality measures for HF, and improve national standardization of diagnosis and treatment of HF. Since the establishment of the Heart Failure Medical Union of the National Center for Cardiovascular Diseases (HFMU-NCCD) in March 2018, more than 1 000 hospitals all over the country have participated in the HFMU-NCCD. Based on the data from patients hospitalized with HF from 2017 January to 2020 October in some hospitals of HFMU-NCCD nationwide, the Working Group on Heart Failure of National Center for Cardiovascular Quality Improvement (NCCQI-HF) performed national medical quality measures for HF, including the diagnosis and assessment of HF, evidenced-based medical therapy and mechanotherapy, and clinical outcomes, etc, and write this report according to the research results and our thinkings. Moreover, comparison with the American Heart Association (AHA)′s Get With The Guideline-Heart Failure (GWTG-HF) program was made to find the lack of standardization in the diagnosis and treatment of HF in China at present. Then, we will set clear goals and effective methods to carry out quality improvement continuously in the future to improve management of HF in China as a whole.